Organon Shares Rise Following Sun Pharma's Acquisition Agreement
Organon's shares surged 16.87% after Sun Pharmaceutical Industries agreed to acquire the company in an all-cash deal at $14 per share. The acquisition is expected to close in early 2027 following shareholder approval. The news drove significant trading volume, with shares trading 1,618% above the three-month average.
Topics: acquisition merger Organon pharmaceutical stock price movement Sun Pharmaceutical Industries